Related Experiment Video
Updated: Sep 5, 2025
ATAC-Seq Optimization for Cancer Epigenetics Research
Published on: June 30, 2022
Application of ATAC-seq in tumor-specific T cell exhaustion
Chufeng Chen1, Jiaying Liu1, Yidong Chen1
1Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Abstract:
Researches show that chronic viral infection and persistent antigen and/or inflammatory signal exposure in cancer causes the functional status of T cells to be altered, mainly by major changes in the epigenetic and metabolic environment, which then leads to T cell exhaustion. The discovery of the immune checkpoint pathway is an important milestone in understanding and reversing T cell exhaustion. Antibodies targeting these pathways have shown superior ability to reverse T cell exhaustion. However, there are still some limitations in immune checkpoint blocking therapy, such as the short-term nature of therapeutic effects and high individual heterogeneity. Assay for transposase-accessible chromatin with sequencing(ATAC-seq) is a method used to analyze the accessibility of whole-genome chromatin. It uses hyperactive Tn5 transposase to assess chromatin accessibility. Recently, a growing number of studies have reported that ATAC-seq can be used to characterize the dynamic changes of epigenetics in the process of T cell exhaustion. It has been determined that immune checkpoint blocking can only temporarily restore the function of exhausted T cells because of an irreversible change in the epigenetics of exhausted T cells. In this study, we review the latest developments, which provide a clearer molecular understanding of T cell exhaustion, reveal potential new therapeutic targets for persistent viral infection and cancer, and provide new insights for designing effective immunotherapy for treating cancer and chronic infection.
Insights
Chronic viral infections and cancer can lead to T cell exhaustion due to epigenetic changes. Assay for transposase-accessible chromatin with sequencing (ATAC-seq) helps understand these changes and improve cancer immunotherapy.
Area of Science:
- Immunology
- Epigenetics
- Cancer Biology
Background:
- Chronic infections and cancer induce T cell exhaustion by altering epigenetic and metabolic states.
- Immune checkpoint pathways are key targets for reversing T cell exhaustion, with antibodies showing promise.
- Limitations of current therapies include transient effects and patient variability.
Purpose of the Study:
- To review recent advancements in understanding T cell exhaustion.
- To explore the role of Assay for Transposase-Accessible Chromatin with Sequencing (ATAC-seq) in characterizing epigenetic dynamics.
- To identify new therapeutic targets and strategies for cancer and chronic infection immunotherapy.
Main Methods:
- Review of current literature on T cell exhaustion and immunotherapy.
- Discussion of Assay for Transposase-Accessible Chromatin with Sequencing (ATAC-seq) for epigenetic analysis.
- Analysis of molecular mechanisms underlying T cell exhaustion and therapeutic resistance.
Main Results:
- T cell exhaustion is driven by significant epigenetic and metabolic alterations.
- Immune checkpoint blockade offers temporary restoration of T cell function.
- Epigenetic changes in exhausted T cells can be irreversible, limiting long-term therapeutic efficacy.
- ATAC-seq reveals dynamic epigenetic modifications during T cell exhaustion.
Conclusions:
- A deeper molecular understanding of T cell exhaustion is emerging.
- ATAC-seq provides valuable insights into epigenetic landscapes of exhausted T cells.
- New therapeutic targets for cancer and chronic viral infections can be identified.
- Improved immunotherapy strategies for cancer and chronic infections can be developed based on these findings.
